AbbVie ABBV
NYSE ABBV
$265.91 +4.08 (+1.56%)
As of: Aug 21, 2026 · 3:01 PM EDT

AbbVie (ABBV) EBT Margin (2012 - 2026)

AbbVie (ABBV) posted quarterly EBT Margin of 6.93% for Q1 2026, down 552.0% year-over-year from 1.53% in Q1 2025, and down 56.86% quarter-over-quarter from 16.05% in Q4 2025.

AbbVie (ABBV) EBT Margin (2012 - 2026) Analysis & Trends

AbbVie (ABBV) has reported EBT Margin for 15 consecutive years, with 6.93% the latest figure, recorded in Q1 2026.

  • In Q1 2026, EBT Margin fell 552.0% year-over-year to 6.93%; the TTM figure through Mar 2026 stood at 9.51% (up 320.0% YoY), while the FY2025 annual figure was 10.79%, up 419.0% from the prior year.
  • EBT Margin eased to 6.93% in Q1 2026 per ABBV's latest filing, from 16.05% in the prior quarter.
  • Across five years, EBT Margin topped out at 36.41% in Q1 2022 and bottomed at 15.02% in Q4 2024.
  • Historically, EBT Margin has averaged 12.8% across 5 years, with a median of 14.02% in 2023.
  • Annual changes were most pronounced in 2023 — EBT Margin sank 3252 bps — and 2025, when it soared 3108 bps.
  • AbbVie's EBT Margin stood at 19.61% in 2022, then tumbled by 57 bps to 8.47% in 2023, then sank by 277 bps to 15.02% in 2024, then soared by 207 bps to 16.05% in 2025, then slumped by 57 bps to 6.93% in 2026.
  • Business Quant data shows ABBV's EBT Margin at 6.93% in Q1 2026, 16.05% in Q4 2025, and 4.53% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 653.51 Bn 632.75 Bn 17.26 Bn 26.66%
2 AbbVie 470.18 Bn 463.61 Bn 12.70 Bn 25.18%
3 Merck 376.85 Bn 369.71 Bn 12.21 Bn -4.11%
4 Novartis Ag 303.27 Bn 295.58 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.42 Bn 252.52 Bn 12.86 Bn 18.19%
6 Amgen 236.70 Bn 222.71 Bn 7.24 Bn 27.53%
7 Gilead Sciences 182.16 Bn 178.98 Bn 6.22 Bn -131.41%
8 Pfizer 159.30 Bn 147.60 Bn 10.94 Bn -4.34%
9 Gsk 106.12 Bn 101.95 Bn 8.24 Bn 4.21%
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 127.52%

Historic Data

Download Data
DateValue
Jun 30, 2026 25.18%
Mar 31, 2026 6.93%
Dec 31, 2025 16.05%
Sep 30, 2025 4.53%
Jun 30, 2025 10.08%
Mar 31, 2025 12.45%
Dec 31, 2024 -15.02%
Sep 30, 2024 14.41%
Jun 30, 2024 14.84%
Mar 31, 2024 14.26%
Dec 31, 2023 8.47%
Sep 30, 2023 14.02%
Jun 30, 2023 18.82%
Mar 31, 2023 3.89%
Dec 31, 2022 19.61%
Sep 30, 2022 29.71%
Jun 30, 2022 8.11%
Mar 31, 2022 36.41%
Dec 31, 2021 28.69%
Sep 30, 2021 25.71%